Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalev...Show More
competitor of
Metrics
marketSTOCKS
msh_idFI:ORION
localefi
websitehttps://www.orion.fi
ipo_date2004-10-07
primary_stock_msh_idHEL:ORNAV
source_ref7d4a80e4-8397-4c69-8ed8-560170fd8380
products_or_servicesPharmaceutical products, medicines, self-care products, veterinary medicines, active pharmaceutical ingredients, patient safety solutions, and research services.